Milatuzumab (MEDI-115) is a humanized monoclonal antibody against CD74. Milatuzumab promotes the production of free radical oxygen and the loss of mitochondrial membrane potential, reduces CD20/CD74 aggregates and cell adhesion, and induces cell death.
Purity:
>95%
CAS Number:
[899796-83-9]
Target:
CD74|||Others
* VAT and and shipping costs not included. Errors and price changes excepted